Biotech Late Stage Investors & VC Firms
652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.
Franklin Park
PhiladelphiaSeed–Late Stage
1 person
Haibang Capital
HangzhouPre-Seed–Late Stage
1 person
Tera Capital Corporation
StouffvilleLate Stage
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Ikarian Capital
DallasPre-Seed–Late Stage
Worthwhile Industries Campuses
TorontoLate Stage
CEA Investissement
Pre-Seed–Late Stage
Egora Holding
MartinsriedPre-Seed–Late Stage$5.4M
GERBER-RAUTH
MilanPre-Seed–Late Stage
The Wells Investment
SeoulSeed–Late Stage
BioTrack Capital
Grand CaymanSeed–Late Stage
6 people
Boxer Capital, LLC
San DiegoSeed–Late Stage
Estari Group
LondonLate Stage
Morgenthaler
Portola ValleyPre-Seed–Late Stage
6 people
Seoul Investment Partners
SeoulSeed–Late Stage
Yuuwa Capital
PerthPre-Seed–Late Stage
CDF-Capital
ShenzhenSeed–Late Stage
D3 Jubilee
SeoulSeed–Late Stage
Kearny Venture Associates Iii, Llc
Late Stage
Laval Innov
LavalPre-Seed–Late Stage
MagogTechnopole
MagogPre-Seed–Late Stage
North Forge Technology Exchange
WinnipegPre-Seed–Late Stage
Northwestern Ontario Innovation Centre
Thunder BayPre-Seed–Late Stage
Shiyu Capital
HainanSeed–Late Stage
Related lists
Late Stage Investors & VC Firms (2974)Biotech Investors & VC Firms (2185)Biotech Seed Investors & VC Firms (1824)Late Stage Investors & VC Firms in North America (1695)Biotech Series A Investors & VC Firms (1668)Late Stage Investors & VC Firms in United States (1516)Biotech Investors & VC Firms in North America (1391)Biotech Investors & VC Firms in United States (1267)Late Stage Investors & VC Firms in Europe (965)Biotech Pre-Seed Investors & VC Firms (957)
Data sourced from public filings and firms' own websites — see our methodology.







